Name | Number of supported studies | Average coverage | |
---|---|---|---|
T cell | 8 studies | 32% ± 9% | |
epithelial cell | 7 studies | 26% ± 11% | |
natural killer cell | 7 studies | 44% ± 21% | |
B cell | 6 studies | 27% ± 8% | |
hematopoietic precursor cell | 6 studies | 32% ± 20% | |
plasmablast | 6 studies | 44% ± 19% | |
CD8-positive, alpha-beta T cell | 6 studies | 41% ± 14% | |
progenitor cell | 5 studies | 30% ± 16% | |
abnormal cell | 5 studies | 23% ± 6% | |
erythroblast | 5 studies | 44% ± 16% | |
pro-B cell | 5 studies | 36% ± 7% | |
CD4-positive, alpha-beta T cell | 5 studies | 43% ± 14% | |
transit amplifying cell | 4 studies | 34% ± 17% | |
erythrocyte | 4 studies | 42% ± 20% | |
effector CD8-positive, alpha-beta T cell | 4 studies | 33% ± 14% | |
endothelial cell | 3 studies | 24% ± 9% | |
neural crest cell | 3 studies | 35% ± 13% | |
pericyte | 3 studies | 19% ± 2% | |
common myeloid progenitor | 3 studies | 24% ± 3% | |
hematopoietic stem cell | 3 studies | 20% ± 1% | |
plasma cell | 3 studies | 41% ± 14% | |
basal cell | 3 studies | 21% ± 7% | |
granulocyte monocyte progenitor cell | 3 studies | 38% ± 26% | |
regulatory T cell | 3 studies | 31% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 5501.88 | 170 / 170 | 100% | 235.85 | 457 / 459 |
skin | 100% | 7031.66 | 1809 / 1809 | 99% | 159.09 | 468 / 472 |
ovary | 100% | 5516.17 | 180 / 180 | 99% | 100.93 | 425 / 430 |
brain | 100% | 4349.66 | 2637 / 2642 | 99% | 120.81 | 696 / 705 |
bladder | 100% | 5089.14 | 21 / 21 | 98% | 158.69 | 496 / 504 |
esophagus | 100% | 5021.31 | 1445 / 1445 | 98% | 129.33 | 180 / 183 |
breast | 100% | 5105.91 | 459 / 459 | 98% | 107.52 | 1095 / 1118 |
intestine | 100% | 5776.45 | 966 / 966 | 98% | 176.60 | 514 / 527 |
lung | 100% | 3953.46 | 576 / 578 | 98% | 130.97 | 1130 / 1155 |
pancreas | 100% | 3007.07 | 327 / 328 | 98% | 79.49 | 174 / 178 |
prostate | 100% | 5153.14 | 245 / 245 | 97% | 62.25 | 488 / 502 |
thymus | 100% | 5039.28 | 653 / 653 | 97% | 96.96 | 585 / 605 |
stomach | 100% | 4026.03 | 359 / 359 | 97% | 144.66 | 276 / 286 |
kidney | 100% | 3234.53 | 89 / 89 | 85% | 52.60 | 768 / 901 |
liver | 100% | 1939.50 | 226 / 226 | 78% | 59.12 | 317 / 406 |
adrenal gland | 100% | 3019.08 | 258 / 258 | 59% | 29.58 | 135 / 230 |
adipose | 100% | 4366.85 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 277.05 | 29 / 29 |
spleen | 100% | 7807.71 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 265.87 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 60.39 | 1 / 1 |
blood vessel | 100% | 4050.32 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 3287.35 | 798 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 5954.64 | 882 / 929 | 0% | 0 | 0 / 0 |
heart | 93% | 1638.67 | 798 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 41.33 | 68 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0008283 | Biological process | cell population proliferation |
GO_0006268 | Biological process | DNA unwinding involved in DNA replication |
GO_0006974 | Biological process | DNA damage response |
GO_0042325 | Biological process | regulation of phosphorylation |
GO_0006260 | Biological process | DNA replication |
GO_0000727 | Biological process | double-strand break repair via break-induced replication |
GO_0006270 | Biological process | DNA replication initiation |
GO_0030174 | Biological process | regulation of DNA-templated DNA replication initiation |
GO_0006271 | Biological process | DNA strand elongation involved in DNA replication |
GO_0005730 | Cellular component | nucleolus |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0042555 | Cellular component | MCM complex |
GO_0071162 | Cellular component | CMG complex |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0003697 | Molecular function | single-stranded DNA binding |
GO_0003678 | Molecular function | DNA helicase activity |
GO_0017116 | Molecular function | single-stranded DNA helicase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
Gene name | MCM7 |
Protein name | DNA replication licensing factor MCM7 (EC 3.6.4.12) Minichromosome maintenance complex component 7 isoform 2 DNA replication licensing factor MCM7 (EC 3.6.4.12) (CDC47 homolog) (P1.1-MCM3) |
Synonyms | CDC47 MCM2 |
Description | FUNCTION: Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built . The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity . Required for S-phase checkpoint activation upon UV-induced damage. . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . |
Accessions | C6EMX8 ENST00000710815.1 A0AA34QVT8 A0A0S2Z441 A0A0S2Z4A5 B2RBA6 B3KUD7 C9J8M6 B4DDF5 ENST00000425308.6 ENST00000343023.10 [P33993-2] P33993 ENST00000710814.1 ENST00000710813.1 ENST00000303887.10 [P33993-1] |